152 related articles for article (PubMed ID: 28194882)
1. Is low-molecular-weight heparin beneficial to chronic ulcers? A meta-analysis of randomised control trials.
Huang CY; Choong MY
Int Wound J; 2017 Jun; 14(3):589-590. PubMed ID: 28194882
[No Abstract] [Full Text] [Related]
2. Low-Molecular-Weight Heparins as Immunomodulators in Dermatology Practice.
Solak B
Am J Ther; 2016; 23(6):e1911-e1917. PubMed ID: 25853237
[TBL] [Abstract][Full Text] [Related]
3. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses.
Bergqvist D
Br J Surg; 1998 Jun; 85(6):872. PubMed ID: 9667723
[No Abstract] [Full Text] [Related]
4. Low molecular weight heparins could be important in cancer.
Siragusa S
BMJ; 1999 Sep; 319(7213):851. PubMed ID: 10496841
[No Abstract] [Full Text] [Related]
5. Low-molecular-weight heparin and survival in patients with malignant disease.
Kakkar AK
Cancer Control; 2005 Sep; 12 Suppl 1():22-30. PubMed ID: 16179901
[No Abstract] [Full Text] [Related]
6. Randomized controlled trials of low molecular weight heparin in non-mild acute pancreatitis: A systemic review and meta-analysis.
He K; Zhang Y; Song K; Fan Z; Gong L; Shu H; Wu D
Thromb Res; 2023 Jan; 221():26-29. PubMed ID: 36436442
[No Abstract] [Full Text] [Related]
7. A contemporary assessment of low-molecular-weight heparin for the treatment of acute coronary syndromes: factoring in new trials and meta-analysis data.
Topol EJ
Am Heart J; 2005 Apr; 149(4 Suppl):S100-6. PubMed ID: 16124950
[No Abstract] [Full Text] [Related]
8. Is unfractionated heparin equivalent to low-molecular-weight heparin for venous thromboembolism?
Graber MA; Dachs R; Darby-Stewart A
Am Fam Physician; 2008 Jun; 77(11):1492-3. PubMed ID: 18581828
[No Abstract] [Full Text] [Related]
9. [The treatment of deep venous thrombosis with low-molecular-weight heparin].
Samama MM; Achkar A; Horellou MH
Rev Med Brux; 1995; 16(4):304-9. PubMed ID: 7481248
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis.
Hirsh J
Semin Hematol; 1997 Oct; 34(4 Suppl 4):20-5. PubMed ID: 9399406
[No Abstract] [Full Text] [Related]
11. Low molecular weight heparin: a bridge over troubled water.
Verheugt FW
Eur Heart J; 2002 Aug; 23(15):1144-6. PubMed ID: 12127917
[No Abstract] [Full Text] [Related]
12. Low-molecular-weight heparin therapy in children.
Massicotte MP
J Pediatr Hematol Oncol; 2001; 23(3):189-94. PubMed ID: 11305725
[No Abstract] [Full Text] [Related]
13. Low molecular weight heparin and unfractionated heparin for prevention of thrombo-embolism in general surgery: a meta-analysis of randomised clinical trials.
Palmer AJ; Schramm W; Kirchhof B; Bergemann R
Haemostasis; 1997; 27(2):65-74. PubMed ID: 9212354
[TBL] [Abstract][Full Text] [Related]
14. Current use of low molecular weight heparins.
Donayre CE
Semin Vasc Surg; 1996 Dec; 9(4):362-71. PubMed ID: 8958613
[No Abstract] [Full Text] [Related]
15. [Internist patients are strongly thrombosis endangered. CERTIFY study has arrived].
MMW Fortschr Med; 2007 May; 149(20):52-3. PubMed ID: 18051966
[No Abstract] [Full Text] [Related]
16. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.
Sandercock PA; Counsell C; Tseng MC
Cochrane Database Syst Rev; 2008 Jul; (3):CD000119. PubMed ID: 18646059
[TBL] [Abstract][Full Text] [Related]
17. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.
Sandercock P; Counsell C; Stobbs SL
Cochrane Database Syst Rev; 2005 Apr; (2):CD000119. PubMed ID: 15846600
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication.
Cosmi B; Conti E; Coccheri S
Cochrane Database Syst Rev; 2001; (3):CD001999. PubMed ID: 11687006
[TBL] [Abstract][Full Text] [Related]
19. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials.
Gould MK; Dembitzer AD; Doyle RL; Hastie TJ; Garber AM
Ann Intern Med; 1999 May; 130(10):800-9. PubMed ID: 10366369
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of low molecular weight heparin, unfractionated heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery: a meta-analysis of randomised clinical trials.
Palmer AJ; Koppenhagen K; Kirchhof B; Weber U; Bergemann R
Haemostasis; 1997; 27(2):75-84. PubMed ID: 9212355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
